Dr. Gidley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
441
Houston, TX 77030Phone+1 713-792-6920Fax+1 713-794-4662
Summary
- Dr. Paul Gidley is an otolaryngologist in Houston, TX and is affiliated with multiple hospitals in the area, including University of Texas M.D. Anderson Cancer Center and Houston Methodist Hospital. He received his medical degree from University of Texas Medical School and has been in practice 27 years. He also speaks multiple languages, including Spanish. He specializes in neurotology and is experienced in otology / neurotology.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Neurotology, 1996 - 1997
- University of Texas Health Science Center at HoustonResidency, Otolaryngology - Head and Neck Surgery, 1990 - 1995
- McGovern Medical School at UTHealthClass of 1990
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- TN State Medical License 2023 - 2026
- WA State Medical License 2023 - 2026
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Otolaryngology - Head and Neck Surgery Neurotology
- Join now to see all
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Society
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Publications & Presentations
PubMed
- The Effects of Metformin on Cisplatin-Induced Ototoxicity in Diabetic Patients.Marc-Elie Nader, Jonathan Choi, Mike Hernandez, Katherine Hutcheson, Taylor Myers
Otolaryngology--Head and Neck Surgery. 2024-10-26 - 1 citationsLosartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing Loss During Observation.Benjamin D Lovin, Marc-Elie Nader, Yun Qing, Mike Hernandez, Shaan Raza
Otology & Neurotology. 2024-07-01 - Survival Outcomes of Temporal Bone Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.Krystelle Sioufi, Aaron David Haynes, Paul W Gidley, Anastasios Maniakas, Dianna Roberts
Otolaryngology--Head and Neck Surgery. 2024-07-01
Press Mentions
- Nasopharyngeal Carcinoma Survivor: My Journey to Becoming an OncologistAugust 17th, 2020
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: